Today, only 1 out of 20 cancer patients1 enroll in a clinical trial. For melanoma patients, while therapies have improved dramatically, we’re far from a cure for all patients.
Clinical trials offer patients access to treatment approaches that may prove more beneficial than anything currently approved by the FDA. In addition, clinical trials drive our understanding of melanoma forward, improving future treatment options for all patients.
Lack of enrollment in clinical trials is one of the biggest obstacles to bringing new therapies to market2 and today there are more than 500 melanoma-focused clinical trials currently recruiting patients. Without patient volunteers, our entire medical research process would stop.
Get matched to a melanoma clinical trial that's right for you. Print your results or contact study coordinators directly to get started!
Melanoma clinical trials are research studies involving human volunteers that are designed to answer specific questions about new treatments for melanoma. The answers gained through the research helps doctors find new ways to improve outcomes for people with melanoma.
Researchers rely on medical organizations, such as cancer centers, hospitals and medical centers, to find clinical trial participants.
Although clinical trials can provide the latest, most advanced treatment, they are not without risk.
Being informed about all of your options is an important step toward being an empowered patient.
